RMACT’s IVF with PGS Opportunity Plan is the only all-inclusive IVF treatment plan that includes embryo screening.
When IVF is required for a patient to conceive, RMACT has the ability to screen each embryo for chromosomal abnormalities be- fore the embryo is transferred back into the uterus. The purpose of Preimplantation Genetic Screening (PGS ) is to identify and only transfer embryos that do not have abnormalities in their number of chromosomes. These chromosomal abnormalities – termed Aneuploidy – refer to the unbalanced number of chromosomes that can be passed down from the egg or sperm. Screening embryos in advance can help achieve higher implantation rates and fewer pregnancy losses. Patients who could benefit from PGS include: women 35 or older, those with multiple-failed IVF cycles and patients with recurrent miscarriages.
To help make this advanced technology accessible to as many patients as possible, RMA of Connecticut offers our IVF with PGS Opportunity Plan. This unique payment plan is available exclusively to RMACT patients who do not have insurance coverage for their fertility treatments.
Patients who choose The IVF with PGS Opportunity Plan at RMACT are treated by our outstanding team of physicians, nurses and other specially trained patient care professionals. Find out if The IVF with PGS Opportunity Plan is right for you. To learn more, speak with a Financial Service Representative at RMACT at 203 750-7400 or contact us here.